232 related articles for article (PubMed ID: 33693586)
1. Association of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa.
Cogen JD; Onchiri FM; Hamblett NM; Gibson RL; Morgan WJ; Rosenfeld M
Clin Infect Dis; 2021 Sep; 73(6):987-993. PubMed ID: 33693586
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
3. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics and outcomes of CF pulmonary exacerbations in children infected with MRSA and Pseudomonas aeruginosa.
Cogen JD; Hall M; Faino AV; Ambroggio L; Blaschke AJ; Brogan TV; Cotter JM; Gibson RL; Grijalva CG; Hersh AL; Lipsett SC; Shah SS; Shapiro DJ; Neuman MI; Gerber JS
J Cyst Fibros; 2023 Mar; 22(2):313-319. PubMed ID: 35945130
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without
Cogen JD; Faino AV; Onchiri F; Gibson RL; Hoffman LR; Nichols DP; Rosenfeld M; Kronman MP
Ann Am Thorac Soc; 2022 Aug; 19(8):1320-1327. PubMed ID: 35289740
[No Abstract] [Full Text] [Related]
6. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
[TBL] [Abstract][Full Text] [Related]
7. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
Mayer-Hamblett N; Kronmal RA; Gibson RL; Rosenfeld M; Retsch-Bogart G; Treggiari MM; Burns JL; Khan U; Ramsey BW;
Pediatr Pulmonol; 2012 Feb; 47(2):125-34. PubMed ID: 21830317
[TBL] [Abstract][Full Text] [Related]
8. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
[TBL] [Abstract][Full Text] [Related]
9. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.
Treggiari MM; Rosenfeld M; Mayer-Hamblett N; Retsch-Bogart G; Gibson RL; Williams J; Emerson J; Kronmal RA; Ramsey BW;
Contemp Clin Trials; 2009 May; 30(3):256-68. PubMed ID: 19470318
[TBL] [Abstract][Full Text] [Related]
10. Nebulized gentamicin in combination with systemic antibiotics for eradicating early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Van Stormbroek B; Zampoli M; Morrow BM
Pediatr Pulmonol; 2019 Apr; 54(4):393-398. PubMed ID: 30656856
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
[TBL] [Abstract][Full Text] [Related]
12. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.
Palser S; Smith S; Nash EF; Agarwal A; Smyth AR
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012300. PubMed ID: 31845758
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.
Merlo CA; Boyle MP; Diener-West M; Marshall BC; Goss CH; Lechtzin N
Chest; 2007 Aug; 132(2):562-8. PubMed ID: 17646236
[TBL] [Abstract][Full Text] [Related]
14. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
[TBL] [Abstract][Full Text] [Related]
15. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Greally P; Whitaker P; Peckham D
Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
[TBL] [Abstract][Full Text] [Related]
16. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
17. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.
McCoy KS; Quittner AL; Oermann CM; Gibson RL; Retsch-Bogart GZ; Montgomery AB
Am J Respir Crit Care Med; 2008 Nov; 178(9):921-8. PubMed ID: 18658109
[TBL] [Abstract][Full Text] [Related]
18. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
Mayer-Hamblett N; Rosenfeld M; Treggiari MM; Konstan MW; Retsch-Bogart G; Morgan W; Wagener J; Gibson RL; Khan U; Emerson J; Thompson V; Elkin EP; Ramsey BW; ;
Pediatr Pulmonol; 2013 Oct; 48(10):943-53. PubMed ID: 23818295
[TBL] [Abstract][Full Text] [Related]
19. The effect of Pseudomonas aeruginosa eradication regimens on chronic colonization and clinical outcomes in pediatric patients with cystic fibrosis.
Nayir Buyuksahin H; Yalçın E; Emiralioglu N; Hazırolan G; Ademhan Tural D; Ozsezen B; Sunman B; Guzelkas I; Dogru D; Ozcelik U; Kiper N
Pediatr Int; 2022 Jan; 64(1):e15249. PubMed ID: 36321341
[TBL] [Abstract][Full Text] [Related]
20. Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.
Mayer-Hamblett N; Retsch-Bogart G; Kloster M; Accurso F; Rosenfeld M; Albers G; Black P; Brown P; Cairns A; Davis SD; Graff GR; Kerby GS; Orenstein D; Buckingham R; Ramsey BW;
Am J Respir Crit Care Med; 2018 Nov; 198(9):1177-1187. PubMed ID: 29890086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
